We use private and third party cookies to enhance the browsing experience. If you continue to browse by using the scrollbars, clicking on any link, or by closing the present dialogue, we understand you accept our cookie policy.


Follow us on:


CIC biomaGUNE is a non-profit research organization created to promote scientific research and technological innovation at the highest levels in the Basque Country following the BIOBASQUE policy in order to create a new business sector based on biosciences.


Research Highlights

The researchers Dr. Abraham Martín and Dr. Jordi Llop of the Molecular Imaging Unit of CICbiomaGUNE in collaboration with the researchers Dr. Maria Domercq and Prof. Carlos Matute of the Achucarro Center and the UPV/EHU have discovered a new therapeutic target for brain damage resulting from stroke.

Title: Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage.
Authors: Soria FN, Pérez-Samartín A, Martin A, Gona KB, Llop J, Szczupak B, Chara JC, Matute C, Domercq M.
Journal: Journal of Clinical Investigation 2014; 124(8):3645-55.

Cerebral ischemia...




Dr. Abraham Martin

Brain Imaging of neurologic diseases: focus on Stroke and Multiple Sclerosis